These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1881432)

  • 21. Dystrophin and muscular dystrophy: past, present, and future.
    O'Brien KF; Kunkel LM
    Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
    Stedman HH
    Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular therapy for muscular dystrophy].
    Shimizu Y; Takeda S
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():650-3. PubMed ID: 20976941
    [No Abstract]   [Full Text] [Related]  

  • 24. [Expression of the human dystrophin gene in mdx mouse muscle fibers after transfection using liposomes and synthetic oligopeptides].
    Baranov VS; Tarasenko OV; Baranov VS; Tarasenko OV; Baranov AN; Kiselev AV; Ivashchenko TE; Evgrafov OV; Mikhailov Vm; Dickson G
    Genetika; 1998 Jul; 34(7):876-82. PubMed ID: 9749328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional enhancement of skeletal muscle by gene transfer.
    Gregorevic P; Chamberlain JS
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):875-87, vii-viii. PubMed ID: 16214049
    [No Abstract]   [Full Text] [Related]  

  • 26. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.
    Liang KW; Nishikawa M; Liu F; Sun B; Ye Q; Huang L
    Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments in gene therapy for muscular dystrophy.
    Hartigan-O'Connor D; Chamberlain JS
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New gene therapy technique shows some muscle.
    Schub T
    Lab Anim (NY); 2004 Sep; 33(8):8-9. PubMed ID: 15334094
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia].
    Baranov VS; Baranov AN; Zelenin AV
    Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of new therapy on muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene transfer therapy for heritable disease: cell and expression targeting.
    Mitani K; Clemens PR; Moseley AB; Caskey CT
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):217-24. PubMed ID: 8097051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dependence of the efficacy of transfecting muscle fibers in vivo on electroporation conditions].
    Ostapenko OV; Boĭtsov AS; Baranov AN; Lesina EA; Mikhaĭlov VM; Baranov VS
    Genetika; 2004 Jan; 40(1):41-8. PubMed ID: 15027199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
    Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
    Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene transfer in skeletal muscle cell and gene therapy].
    Tian J; Zheng S
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):556-8. PubMed ID: 9772455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.